Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study

Kyaw Zin Thein, Siqing Fu, Filip Janku, Apostolia M. Tsimberidou, Sarina A. Piha-Paul, Daniel D. Karp, Jatin Shah, Denái R. Milton, Jing Gong, Selma Sulovic, Lacey McQuinn, Bettzy A. Stephen, Rivka R. Colen, Brett W. Carter, Funda Meric-Bernstam, Aung Naing

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)10-12
Number of pages3
JournalJournal of Immunotherapy and Precision Oncology
Issue number1
StatePublished - Feb 2022


  • Carboplatin
  • Metastatic solid tumors
  • Pemetrexed
  • Selective inhibitor of nuclear export (SINE)
  • Selinexor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Cite this